おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amyloid Solution
company
About
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ₩14.50B
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
₩14.50B
Amyloid Solution has raised a total of
₩14.50B
in funding over 2 rounds. Their latest funding was raised on
Mar 26, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 26, 2019 | Series A | ₩14.50B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Amyloid Solution is funded by 2 investors.
Innopolis Partners
and Saehan Startup Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Innopolis Partners
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
